Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
NCT03410446
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Depression
Cancer
Palliative Care
Interventions
DRUG:
Ketamine Hydrochloride
Sponsor
University Health Network, Toronto